These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26702847)

  • 21. Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide.
    Stanley S; Wynne K; Bloom S
    Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G693-7. PubMed ID: 15068960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of gut hormones in obesity.
    Jayasena CN; Bloom SR
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):769-87, xi. PubMed ID: 18775363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut hormones as therapeutic agents in treatment of diabetes and obesity.
    Tan T; Bloom S
    Curr Opin Pharmacol; 2013 Dec; 13(6):996-1001. PubMed ID: 24060699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxyntomodulin and Glicentin May Predict the Effect of Bariatric Surgery on Food Preferences and Weight Loss.
    Nielsen MS; Ritz C; Wewer Albrechtsen NJ; Holst JJ; le Roux CW; Sjödin A
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 32016415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut peptides and the regulation of appetite.
    Huda MS; Wilding JP; Pinkney JH
    Obes Rev; 2006 May; 7(2):163-82. PubMed ID: 16629873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones.
    Meek CL; Lewis HB; Reimann F; Gribble FM; Park AJ
    Peptides; 2016 Mar; 77():28-37. PubMed ID: 26344355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of gastrointestinal and adipose tissue peptides in childhood obesity and changes after weight loss due to lifestyle intervention.
    Roth CL; Reinehr T
    Arch Pediatr Adolesc Med; 2010 Feb; 164(2):131-8. PubMed ID: 20124141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Importance of the Gastrointestinal Tract in Controlling Food Intake and Regulating Energy Balance.
    Monteiro MP; Batterham RL
    Gastroenterology; 2017 May; 152(7):1707-1717.e2. PubMed ID: 28193513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCK, PYY and PP: the control of energy balance.
    Simpson K; Parker J; Plumer J; Bloom S
    Handb Exp Pharmacol; 2012; (209):209-30. PubMed ID: 22249816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity and appetite control.
    Suzuki K; Jayasena CN; Bloom SR
    Exp Diabetes Res; 2012; 2012():824305. PubMed ID: 22899902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bowels control brain: gut hormones and obesity.
    Field BC; Chaudhri OB; Bloom SR
    Nat Rev Endocrinol; 2010 Aug; 6(8):444-53. PubMed ID: 20585346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination gut hormones: prospects and questions for the future of obesity and diabetes therapy.
    Khoo B; Tan TM
    J Endocrinol; 2020 Sep; 246(3):R65-R74. PubMed ID: 32438346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling oxyntomodulin, GLP1's enigmatic brother.
    Pocai A
    J Endocrinol; 2012 Dec; 215(3):335-46. PubMed ID: 23019069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut hormones and appetite control.
    Hameed S; Dhillo WS; Bloom SR
    Oral Dis; 2009 Jan; 15(1):18-26. PubMed ID: 18939959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Neuropeptide Y and Peptide YY in the Development of Obesity via Gut-brain Axis.
    Wu Y; He H; Cheng Z; Bai Y; Ma X
    Curr Protein Pept Sci; 2019; 20(7):750-758. PubMed ID: 30678628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut hormones in the control of appetite.
    Murphy KG; Bloom SR
    Exp Physiol; 2004 Sep; 89(5):507-16. PubMed ID: 15184357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cracking the combination: Gut hormones for the treatment of obesity and diabetes.
    Alexiadou K; Anyiam O; Tan T
    J Neuroendocrinol; 2019 May; 31(5):e12664. PubMed ID: 30466162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin.
    Kosinski JR; Hubert J; Carrington PE; Chicchi GG; Mu J; Miller C; Cao J; Bianchi E; Pessi A; Sinharoy R; Marsh DJ; Pocai A
    Obesity (Silver Spring); 2012 Aug; 20(8):1566-71. PubMed ID: 22421924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The gut hormones in appetite regulation.
    Suzuki K; Jayasena CN; Bloom SR
    J Obes; 2011; 2011():528401. PubMed ID: 21949903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxyntomodulin : a novel potential treatment for obesity.
    Druce MR; Bloom SR
    Treat Endocrinol; 2006; 5(5):265-72. PubMed ID: 17002486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.